ALMR.US Alamar Biosciences, Inc. Common Stock

Healthcare Health Care Equipment & Supplies USA Stocks
30.81 USD
Close of Nov 14, 2026
17.00 39.61
Market cap
USD 2.14B
P/E
-
P/B
7.28x
ROE
-21.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is ALMR.US undervalued?

Graham number

The Graham number of Alamar Biosciences, Inc. Common Stock cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Alamar Biosciences, Inc. Common Stock fundamental analysis

No fundamental analysis for Alamar Biosciences, Inc. Common Stock yet.

Alamar Biosciences, Inc. Common Stock stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Alamar Biosciences, Inc. Common Stock

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the conti…

Full company profile